Cargando…
The Waning of BNT162b2 Vaccine Effectiveness for SARS-CoV-2 Infection Prevention over Time: A Test-Negative Study in Health Care Professionals of a Health Department from January 2021 to December 2021
The duration of protection of vaccines against SARS-CoV-2 infection has been evaluated in previous studies, but uncertainty remains about the persistence of effectiveness over time and the ideal timing for booster doses. Therefore, the aim of this study was to evaluate BNT162b2 vaccine effectiveness...
Autores principales: | Jiménez-Sepúlveda, Natali, Chico-Sánchez, Pablo, Castro-García, José Miguel, Escribano-Cañadas, Isabel, Merino-Lucas, Esperanza, Ronda-Pérez, Elena, Sánchez-Payá, José, Gras-Valentí, Paula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653695/ https://www.ncbi.nlm.nih.gov/pubmed/36360764 http://dx.doi.org/10.3390/ijerph192113884 |
Ejemplares similares
-
Efectividad de la vacuna BNT162b2 para prevenir la COVID-19 en personal sanitario
por: Chico-Sánchez, Pablo, et al.
Publicado: (2022) -
Reviewers' January—December 2021
Publicado: (2022) -
Waning Immunity after the BNT162b2 Vaccine in Israel
por: Goldberg, Yair, et al.
Publicado: (2021) -
Waning Effectiveness of the BNT162b2 Vaccine Against Infection in Adolescents
por: Prunas, Ottavia, et al.
Publicado: (2022) -
Update on Vaccine-Derived Poliovirus Outbreaks — Worldwide, January 2021–December 2022
por: Bigouette, John Paul, et al.
Publicado: (2023)